bone marrow mononuclear cells from Daam2 tm1a/tm1a mice showed no difference in 3 9 9
osteoclastogenesis, and primary osteoblast mineralization was also similar to wild-type ( carbonate substitution ( Figure S13 ). This decrease in mineral to matrix ratio explains the overall 4 0 4 decrease in bone mineral content observed in the absence of a decrease in cortical bone size.
0 5
While bone size and geometry play a major role in controlling bone strength, decreases in 4 0 6 mineral to matrix ratio are associated with decreased bone stiffness and decreased bending 4 0 7 moment. 29 These decreases in bone composition likely contributed to the poor bone quality Taken together, these data suggest the decreased bone strength in Daam2 tm1a/tm1a mice is not and fragility fracture. While DAAM2 represents the detailed validation of a novel Target Gene and the rapid- eBMD Target Genes that result in contrasting abnormalities of bone structure and strength importance for further study. protein family that mediates gene silencing but has no reported role in the skeleton 30 .
2 5
Homozygous deletion of Cbx1 resulted in embryonic lethality whereas adult heterozygous mice 4 2 6
had increased bone mineral content and trabecular thickness resulting in increased stiffness 4 2 7
and strength (Table S17, Figure S14 ). CBX1 was identified by five SNPs with log10 BFs > 2 4 2 8 mapping directly to its gene body (Table S11 ) and rs208016 (70 kbp upstream) suggested an 4 2 9 association with fracture (P = 1.5x10 -5 ). heterozygous mice had increased bone length, mass and strength (Table S17, Figure S15 ).
3 5
Seven fine-mapped SNPs mapped proximally or directly to WAC (Table S11) , with two fine-
mapped SNPs, rs17686203 (log10 BF = 3.1) and rs61848479 (log10 BF = 3.9) mapping to 4 3 7
WAC promoter Hi-C interaction peaks in primary human osteoblasts, and for the latter SNP in 4 3 8 primary human osteocytes (Table S14) . We also identified rs17753457 (60 kbp downstream) 4 3 9
that had a suggestive association with fracture (P = 4.3x10 -5 ). intronic DSCC1 Hi-C promoter interaction peak in primary human osteoblasts. rs546691328 1, which regulates cell proliferation and apoptosis but has no documented role in the skeleton 33 .
5 2
Nevertheless, Rgcc -/-knockout mice displayed increased bone mineral content and strength Epsilon Isoform, a pro-inflammatory cytokine that mediates signal transduction by binding to brittle bones (Table S17, Figure S18 ). YWHAE was identified in our target gene approach by
22 SNPs with log10 BFs > 2 (Table S11 ) all mapping directly to YWHAE introns and an (P = 7.1x10 -5 ). at least two standard deviations from the expected range ( Figure S19 ). Our data also support
functional experiments in human cells as all five genes were expressed in all four human
osteoblast cell lines we profiled with RNA-seq and ATAC-seq (Online Methods), except for 4 7 7
RGCC which was highly expressed in SaOS-2 with low expression levels in U2OS, MG63, and
HOS. In addition, we observed suggestive association at each locus with fracture (Table S21) ,
further supporting evidence for these five genes having roles in human bone biology. In this, the most comprehensive human and murine study on the genetic determinants of bone 4 8 3 density and fracture performed to date, we have identified a total of 518 genome-wide 4 8 4 significant loci, of which 301 are novel and together explain 20% of the total variance in eBMD.
8 5
In a GWAS meta-analysis of up to 1.2 million individuals, 13 fracture loci were identified, all of 4 8 6
which were also associated with eBMD. through the STARLinG approach, were strongly enriched for genes that are known to play Target Genes revealed enrichment of outlier skeletal phenotypes compared to analysis of 526 4 9 3 unselected knockout lines. Last, we identified DAAM2 as a protein with critical effects on bone
strength, porosity and quality. These findings will enable on-going and future studies to better
understand the genomic characteristics that link fine-mapped SNPs to sets of genes enriched
for causal proteins. Further, this comprehensive study of the genetic variants associated with 4 9 7 osteoporosis will provide opportunities for biomarker and drug development The polygenicity of eBMD is striking. Few traits and diseases currently have hundreds of loci 5 0 0 associated at genome-wide levels of significance. 12, 36 This has led to a large proportion of total perturbation of even only one protein identified in our GWAS can have clinically relevant effects.
0 5
For example, RANKL inhibition has been shown to increase bone density by up to 21% after ten 5 0 6
years of therapy. 38 Interestingly, the genetic variants near RANKL have small effects on eBMD.
0 7
Thus, despite the small effect sizes for most identified variants, these do not necessarily reflect because common genetic variants tend to have small effects on protein function, whereas
pharmacotherapies tend to have large effects on protein function. Consequently, the dose-
response curve describing the effect of small and large genetic perturbations on eBMD is
needed to decide which proteins to target for drug development. Polygenicity has also improved our statistical power to validate STARLinG, which aims to link an
associated locus with a potentially causal gene. We found that fine-mapped sets of SNPs were
able to identify Target Genes that were strongly enriched for positive control genes-particularly
when the STARLinG approach implemented relatively simple strategies, such as the nearest observed that fine-mapped SNPs were often in 3D contact with Target Genes in human
osteoblasts and osteocytes. These rich data, surveying many genomic landscape features provide guidance for investigators attempting to identify causal genes from GWAS-associated
SNPs and all human genetic and murine results are available for download (see URLs). The marked reduction in bone strength in Daam2 tm1a/tm1a mice, despite minimal changes in bone Our GWAS for fracture risk identified 13 loci associated with this common disease. All these loci determinant of fracture risk, at least in the age range assessed within the UK Biobank. While
BMD-independent loci for fracture likely exist, these were not identified despite a well-powered
study. This suggests that screening for fracture drug targets should also include understanding
the effect of the protein on BMD. Our study has important limitations. First, we have measured eBMD, rather than DXA-derived sample sizes with RNA-sequencing data will be required to properly investigate our method of other populations remains to be assessed. It is likely that on-going studies in non-British 5 5 7
ancestries will address this question. In summary, we have generated an atlas of human and murine genetic influences on
osteoporosis. This comprehensive study has more fully described the genetic architecture of identifying DAAM2, a gene whose disruption in mice leads to an increase in cortical porosity and treatment of osteoporosis, a common disease for which novel therapeutic options are a health 5 6 7 priority. Bedford, Massachusetts, USA). Further information regarding the assessment protocols are description of the ascertainment procedure is provided in Figure S1 . Prior to quality control, and/or BUA measurements. To achieve this, subjects were stratified by sex and bivariate scatter 5 8 7
plots comparing left and right heel measures of SOS and BUA were generated separately.
8 8
Outliers were identified by manual inspection and removed. The same method was used to 5 8 9
identify and remove individuals with highly discordant SOS v BUA measured for each heel.
Strict quality control was thereafter applied to male and female subjects separately using the Individuals exceeding the threshold for SOS or BUA or both were removed from the analysis. Estimated bone mineral density [eBMD, (g/cm2) ] was derived as a linear combination of SOS Individuals with a valid right calcaneus measure were included in the final data set when no left used to curate the raw data is available on request, together with all supporting summary data 6 0 5
and plots. Descriptive statistics of the cohort, after quality control, are detailed in Table S1 .
Fracture cases were identified using two mutually non-exclusive methods: Hospital Episodes data. We excluded fractures of the skull, face, hands and feet, pathological fractures due to ICD10 codes used can be found in Table S22 . We did not exclude any self-reported fracture cases by fracture site, since participants were only asked if they sustained a fracture at ankle,
leg, hip, spine, write, arm, other or unknown. We identified 20,122 fractures using ICD10 codes and 48,818 using questionnaire-based self-reported data. Descriptive statistics of the cohort,
after quality control and ancestry selection, are detailed in Table S1 . Biobank, using a combination of self-reported ethnicity and genetic information. However, the 6 2 6
reliance on self-reported information was deemed too conservative and we chose to redefine a 6 2 7
White-British sample (N = 440,414) using genetic information only. We projected the UK 6 2 8
Biobank sample onto the first 20 principal components estimated from the 1000 Genomes 6 2 9
Phase 3 (1000G) project data 44 (where ancestry was known) using FastPCA version 2. SNPs that were shared between the 1000G and UK Biobank datasets (i.e. MAF > 1%, minor
allele count > 5, genotyping call rate > 95%, Hardy-Weinberg P > 1x10 -6 , and regions of 6 3 3
extensive LD removed). Expectation Maximization (EM) clustering (as implemented in R using
EMCluster 47 ) was used to compute probabilities of cluster membership based on a finite mixture
of multivariate Gaussian distributions with unstructured dispersion. Eigenvectors 1, 2 and 5
were used for clustering as they represented the smallest number of eigenvectors that were
able to resolve the British 1000G sub-population (GBR) from other ethnicities ( Figure S20 ).
Twelve predefined clusters were chosen for EM clustering as sensitivity analyses suggested
that this number provided a good compromise between model fit (as quantified by log likelihood,
Bayesian information criterion, and Akaike information criterion) and computational burden GBR sub-population were termed White-British and used for downstream genetic analyses Genome-wide complex trait analysis (GCTA) 48 was used to construct a genetic relatedness between individuals j and k (A jk ) was estimated by:
where x ij is the number of copies of the reference allele for the i th SNP of the j th and k
individuals and p i is the frequency of the reference allele across the N individuals. Two samples of unrelated individuals were defined from the White-British UK Biobank the analyses for the X chromosome data were based upon observed genotypes, we excluded
SNPs with evidence of deviation from Hardy-Weinberg Equilibrium (P < 1×10 -6 ), MAF < 0.05%, Manhattan plots of our genome-wide association scans were generated using the same 6 9 0 software. We have previously estimated the genome-wide significance threshold α = 6.6x10 -9 for 6 9 1
analyzing data from the UK Biobank using the above critera. estimates and standard errors of the UK Biobank discovery and 23andMe replication data, we
had to transform the UK Biobank discovery effect estimates and standard errors as per the 7 0 2 manual specifications in the BOLT-LMM 49 documentation, specifically:
where ߤ = case fraction and standard errors of SNP effect estimates should also be divided by
Approximate conditional association analysis
To detect multiple independent association signals at each of the genome-wide significant 7 0 8
eBMD and fracture loci, we applied approximate conditional and joint genome-wide association 7 0 9
analysis using the software package GCTA v1.91. 19 Variants with high collinearity (multiple
regression R 2 > 0.9) were ignored and those situated more than 20 Mbp away were assumed to Estimating genomic inflation with LD Score Regression (LDSC)
To estimate the amount of genomic inflation present in the data that was due to residual
population stratification, cryptic relatedness, and other latent sources of bias, we used stratified
LDSC 59 in conjunction with partitioned LD scores that were calculated for high quality HM3
SNPs derived from a sample of unrelated 1000G GBR individuals. Fine-mapped SNPs were defined as those being conditionally independent, as identified by
GCTA-COJO or exceeding our threshold for posterior probability of causality, as defined by
FINEMAP. Here we describe the generation of this set of fine-mapped SNPs. First, SNPs were defined as being conditionally independent using GCTA-COJO. 19, 20 We next
calculated the posterior probability of causality. To do so, we defined each conditionally-
independent lead SNP as a signal around which, we would undertake posterior probability
testing. We used all imputed SNPs within 500 kbp of a conditionally independent lead SNP and we set to 10. 20 For the causal configuration with the highest posterior probability, each SNP was
assigned a log 10 Bayes factor as a measure of its posterior probability for being in the causal highest posterior probability, all tested SNPs were assigned a Bayes factor for their marginal probabilities. After testing each signal at a locus, the set of fine-mapped SNPs were collapsed
into the same locus, due to the high amount of redundancy between credible sets for each
signal, given that the approximation of genotype-phenotype data with correlation matrices and 7 5 8 summary statistics implemented by FINEMAP is identical to GCTA-COJO. 19, 20 We used a log 10
Bayes factor > 3 threshold to only consider SNPs with the strongest posterior probabilities for 7 6 0 causality, and those SNPs that were identified as genome-wide significant conditionally 7 6 1 independent lead SNPs, as being fine-mapped SNPs. We performed an analysis of whole transcriptome sequencing data of three distinct bone types 7 6 5 from the mouse skeleton to measure osteocyte expression 4 . The three sites were the tibia, deemed to be expressed. Osteocyte enriched genes were determined by comparing the
transcriptomes of matched bone sample controls, one with the marrow removed and the other
with the marrow left intact (N = 5 per site). Genes significantly enriched in osteocytes and
expressed in all bone types were defined as osteocyte transcriptome signature genes. Assay for mapping accessible chromatin sites
ATAC-seq libraries were generated by the McGill University and Genome Quebec Innovation Centre on 100,000 SaOS-2, U2OS, MG63 and HOS cells each, using a modified protocol to that 7 7 7
previously described 62 . The modifications included: reducing the transposase reaction volume
from 50 µl to 25 µl, increasing the transposase concentration from 1x to 40x, and using 12
cycles of PCR to enrich each library. Libraries were quantified by Q-PCR, Picogreen and
LabChip, then were sequenced on the Illumina HiSeq 2500 to 125 bp in pair-ended mode, using (https://github.com/Altius/hotspot2) using a cutoff of 1% FDR and converted to hg19 reference
coordinates using UCSC liftOver. RNA library preparations were carried out on 500 ng of RNA from SaOS-2, U2OS, MG63 and Bioanalyzer and sequenced on the Illumina HiSeq4000 (pair-ended 100 bp sequences). Raw RNA sequencing for murine calvarial osteoblasts
We used whole transcriptome sequencing on mouse osteoblasts post-differentiation to obtain considered enriched for pre-osteoblast cells and was re-plated and subjected to an osteoblast differentiation. We used whole transcriptome sequencing with three technical replicates per 8 0 7
sample and calculated a normalized expression level per gene. High-throughput chromosome conformation capture
High-throughput chromosome conformation capture (Hi-C) was performed on primary human
osteoblasts and osteocytes from human bone biopsies of non-fracture subjects. Hi-C libraries 8 1 2
were prepared as described previously. 68 Instead of using HindIII restriction enzyme, we used were sequenced on Illumina HiSeq4000 instruments to 2 billion pair-end reads. Biological
replicates were independently generated and sequenced. HiC-Pro was used to process the
HiC-Pro pipeline 71 beginning with aligning each read end to hg38 reference genomes. The
Chimeric read ends were filtered to keep only 5′ alignments with MAPQ > 10, and then read-
ends were paired and de-duplicated. Contact matrices were constructed, and significant interaction pairs that were significant (P < 10 -15 ) from all three tools were considered significant.
The resolution of Hi-C interactions was from 1.5 to 2 kbp with average 1.8 kbp. STARLinG: Target Gene identification
We identified Target Genes for the autosomal fine-mapped sets by annotating fine-mapped sets to the gene's introns or exons, or was coding. We identified Target Genes on the X chromosome by the closest gene to a conditionally independent lead SNP, as we did not
calculate log 10 Bayes factors for SNPs on the X chromosome. Additionally, we annotated Target
Genes that may be functional in bone cells by marking which fine-mapped SNPs mapped to
open chromatin in human bone cells, identified by SaOS-2 ATAC-seq peaks, and we mapped protein coding genes, we selected the one with the most significant interaction (usually with highest interaction counts). When the interaction chromatin mapped to multiple bins, we
selected the one(s) with looping domains. We further annotated Target Genes using the
osteocyte signature gene set where genes within this set are enriched for osteocyte activity. We performed a series of enrichment analyses by calculating the odds of Target Genes being mineralization ( Table S12) . 22 For all protein-coding genes in the genome, which were identified 8 4 7
using refGene (N = 19,455), we annotated whether they were found to be Target Genes and/or calculate an odds ratio for enrichment of Target Genes amongst positive control genes. We fine-mapped set SNPs; 2) Genes that contained fine-mapped SNPs overlapping their gene bodies; 3) Genes containing fine-mapped SNPs that are coding variants; 4) Genes identified to
be in 3D contact with fine-mapped sets in human osteoblasts or osteocytes through Hi-C experiments; 5) The closest gene to fine-mapped SNPs, which also mapped to ATAC-seq
peaks in human osteoblast SaOS-2 cell lines; and 6) Those genes within 100 kbp of fine-
mapped SNPs (Figures 2 and 4) . We then repeated this analysis using the osteocyte signature gene set (N = 1,240) instead of the positive control set, to calculate the odds of Target Genes
being active in the osteocyte. second exon of DAAM2 were cloned in the PX458 plasmid (pSpCas9(BB)-2A-GFP; Addgene
#48138). The gRNA sequences were: gRNA 1-CAGAGGGTGGTTGTCCCGG; gRNA 2-8 7 8
CAGCCCCATCCCGAACGCAG; and gRNA 3-TGTCCCGGAGGTTGATTTCG. We observed
the cutting frequency determination (CFD) scores 75 for each gRNA was < 0.1, therefore we did
not consider off-target effects to merit testing 76 . The construct plasmids were purified using the one of the three different plasmids generated, or with the intact plasmid as a control, using
TransIT LT1 transfection reagent (Mirus #MIR2304) with a reagent-to-DNA ratio of 3:1. 48 hours colonies were expanded and then assessed for the presence of DAAM2 protein using
immunofluorescence technique (Anti-DAAM2 antibody, Sigma-Aldrich #HPA051300). PCR (forward: 5′-tcctcttgtccagATCACAATG-3′ and reverse: 5′-ccaagaggagttttgagagatgga-3′) to
generate an amplicon of 355 bp. PCR products of the identified clones were sequenced using MiSeq (Genome Quebec). To generate DAAM2 Western blots ( Figure S23 ), total protein was extracted from SaOS-2 cells 8 9 4
using a RIPA buffer. Denatured proteins (20 µg) were separated by 10% sodium dodecylsulfate 8 9 5
(SDS) polyacrylamide gel electrophoresis followed by transfer to nitrocellulose membranes. The membranes were blocked in 5% skim milk for one hour at room temperature followed by were collected at a resolution of 4.0cm -1 using Happ-Genzel apodization. The wave number 1 0 2 7 data was curve fit to absorbance, with baselining and spectral analyses performed using custom phosphate and amide I peaks; the mineral to matrix ratio, carbonate to phosphate ratio were 1 0 3 2 then calculated using these areas in the appropriate ratios. Collagen maturity and crystallinity
were calculated from the spectral data using absorbance values at literature-reported and closest to a fine-mapped SNP which resided in an SaOS-2 ATAC-seq peak. 5) A fine-mapped 1 0 6 3 SNP was present in a Hi-C osteoblast or osteocyte promoter interaction peak, therefore being
closer to a target gene in three-dimensions than linearly on the genome. female Daam2 tm1a/tm1a (N = 2 from initial OBCD screen) mice is shown in orange (-2.14 SD). outcomes were manually keyed into Vox by the attending healthcare technician or nurse (i.e. measures were excluded from the analysis. Furthermore, quality control was applied to male were removed from the analysis. Estimated bone mineral density [eBMD, (g/cm2)] was derived
as a linear combination of SOS and BUA (i.e. eBMD = 0.002592 * (BUA + SOS) − 3.687). were identified separately across all three time points. Individuals with a valid right calcaneus (264,304 females and 216,073 males). conditionally independent SNPs. the SNP that has the smallest P-value of all conditionally independent SNPs present in the 1 1 4 3 same locus. We emphasize that proximity is not necessarily indicative of causality. independent variants that reach genome-wide significance (P < 6.6 x10 -9 ) for eBMD in the UK
Biobank are plotted. Minus log 10 P-value for the fracture analysis in UK Biobank is represented genome-wide significance for fracture look-up (P < 6.6 x10 -9 ) are labelled in black. (6.6x10 -9 ). In total, 14 conditionally independent SNPs at 13 loci passed the criteria for genome- between males and females. Previously reported loci that reached genome-wide significance (P 1 1 7 1 < 6.6 x10 -9 ) are displayed in red, and previously reported loci failing to reach genome-wide FAM9B had stronger effects on eBMD in males, whereas MCM8 had a larger effect in females. Loci demonstrating significant heterogeneity (P < 6.6 x10 -9 ) but were not robustly associated at an SaOS-2 ATAC-seq peak, and genes identified by fine-mapped SNP was present in a (E) Hi- ATAC-seq open chromatin peaks. RNA of DAAM2 is present in all cell lines, but particularly,
SaOS-2, HOS and U-2_OS cell lines. (blue) and observed by confocal microscopy. showing femur and caudal vertebrae from female (left) and male (right) wild-type (WT; female ranges derived from 320 WT mice, mean (solid line), 1.0SD (dotted lines) and 2.0SD (grey box). Coiled-Coil heterozygous deficient mice (Wac +/-) (a) X-ray microradiography images of femur 1 2 5 7
and caudal vertebrae from female wild-type (WT) and Wac +/-mice at postnatal day 112 (P112). Graphs showing yield load, maximum load and stiffness derived from compression testing of 1 2 6 7 vertebra. Scale bars: a, 1mm and b, 0.5mm. ITU=Indian Telugu from the UK Bayesian information criterion (BIC)]. Twelve predefined clusters were chosen for clustering as and computational burden (i.e. more clusters requires more computation). in Beijing, China, JPT=Japanese in Tokyo, Japan, CHS=Southern Han Chinese, CDX=Chinese Colombia, PEL=Peruvians from Lima, Peru, GIH=Gujarati Indian from Houston, Texas, from the UK, ITU=Indian Telugu from the UK. independent experiments ± SEM. *** represent P < 0.001 compared to control cells determined All Genes Within 100 kbp 6.8 (3.9 -11.7) 2.1x10
-15
Osteocyte Hi-C Interaction Gene NA NA 1 3 8 6 Table 2 . Target gene identification methods enrichment for 1,240 osteocyte signature genes. Distance to gene was determined using 3' and 5' ends, instead of the transcription start 1 3 8 8
site. SaOS-2 ATAC-seq Peak Gene 6.1 (3.5 -10.6) 2.6x10 -13
Overlapping Gene Body 5.1 (3.8 -6.7)
1.1x10
-37
Closest Gene 4.6 (3.7 -5.6) 4.1x10 -53
Osteoblast Hi-C Interaction Gene 3.8 (1.9 -7.4) 2.5x10
-5
Osteocyte Hi-C Interaction Gene 2.9 (1.0 -8.6) 4.0.x10 -2
All Genes Within 100 kbp 2.1 (1.7 -2.5) 
